pre-update Archives

Press Coverage

Fierce Pharma – IRA biosimilar measure intended to boost uptake so far has ‘limited’ impact: report

Check out this article in Fierce Pharma to learn how Certara's US Market Access team…

Certara2024年9月11日

Poster

Dose Selection for DuoBody®-PD-L1x4-1BB (GEN1046)

Abstract DuoBody®-PD-L1x4-1BB (GEN1046) is an investigational, first-in-class, bispecific antibody designed to elicit an antitumor immune…

Certara2024年9月9日

Poster

Optimizing Avidity of Bispecific Drugs

Abstract Bispecific drugs have great potential to improve tissue selectivity through avid binding interactions but…

Certara2024年9月9日

Conference

2024 CDISC Korea Interchange

Certara2024年9月9日

Poster

Effects of Tissue Targeting Bispecifics on Therapeutic Window

Abstract Objectives: The presence of target receptors in non-target tissues can reduce the therapeutic window…

Certara2024年9月9日

お知らせ

サターラ、アジア太平洋地域の医薬品開発リーダー向けにCERTAINTYフォーラム開催

Certara client forums in China, Korea, and Japan support collaboration and networking among drug developers…

Certara2024年9月3日

Publication

Application of physiologically based pharmacokinetic modeling of novel drugs approved by the U.S. food and drug administration

The article from the European Journal of Pharmaceutical Sciences reviews the role of Physiologically Based…

Certara2024年9月1日

Conference Live Events

The 25th Annual Simcyp Consortium Meeting

Every year, the Consortium—comprising over 30 leading biopharmaceutical companies—convenes to discuss Physiologically Based Pharmacokinetic (PBPK)…

Certara2024年9月1日

Fact Sheet

CODEX NSCLC Clinical Outcomes Database

Certara2024年8月30日

SDTM controlled terminology - All You Need to Know

Conference

CDISC US 2024

Certara2024年8月30日

pre-update

Fierce Pharma – IRA biosimilar measure intended to boost uptake so far has ‘limited’ impact: report

Dose Selection for DuoBody®-PD-L1x4-1BB (GEN1046)

Optimizing Avidity of Bispecific Drugs

2024 CDISC Korea Interchange

Effects of Tissue Targeting Bispecifics on Therapeutic Window

サターラ、アジア太平洋地域の医薬品開発リーダー向けにCERTAINTYフォーラム開催

Application of physiologically based pharmacokinetic modeling of novel drugs approved by the U.S. food and drug administration

The 25th Annual Simcyp Consortium Meeting

CODEX NSCLC Clinical Outcomes Database

CDISC US 2024

メルマガ登録

クイックアクセス

ソリューション

お問合せ